Incheon: Samsung E and A Co. announced on Monday that it has secured a 518.6 billion-won (US$354.2 million) contract to construct a biopharmaceutical raw material production and research facility in Songdo, located west of Seoul, for Germany-based Sartorius AG.

According to Lao News Agency, the forthcoming plant will be developed for Sartorius Korea, the South Korean branch of the renowned German life sciences company. The facility will be situated within the Songdo Free Economic Zone in Incheon and will focus on the production of single-use bioprocessing bags and pharmaceutical membrane filters. Additionally, it will offer clinical contract research organization (CRO) services.

Samsung E and A is set to undertake the engineering, procurement, and construction of the facility independently, with the project slated for completion in 2027.